Login
Correlia Biosystems

Correlia Biosystems

Protein tests company based in Berkeley founded by Akwasi Apori

Overview

Correlia Biosystems seeks to develop next-generation proteomics platforms to enable a more data driven approach to biology. Their first commercial platform is for rapid detection of protein biomarkers providing higher resolution and more granular data from research, drug development, diagnostics, and personalized medicine.

History and Technology

The company was founded at UC Berkeley from 2 post-docs and a graduate student from the Herr Lab. The core technology they developed enabled rapid quantification of protein biomarker panels in under 15 min from only 2 microliters of sample.

Fundraising

Correlia launched in the inaugural class of the Foundry incubator at UC Berkeley. During this time they were able to secure grants from the NIH, NSF, and other sources totaling $875K which was used to develop the core technology for commercial use. In 2018, Correlia participated in the Y Combinator W2018 cohort to launch a seed fundraising round.

Timeline

Currently, no events have been added to this timeline yet.
Be the first one to add some.

People

Name
Role
Related Golden topics

Akwasi Apori

Founder

Kursad Araz

Founder

Samuel Tia

Founder

Further reading

Author
Title
Link
Type

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services